The FDA plans to crackdown on alternative remedies; Senator Lamar Alexander, R-Tennessee, says his Obamacare insurer fix will be in the government funding bill; Alabama prepares to drop coverage for 7000 children.
The FDA plans to begin targeting homeopathic medicines that are unproven and pose safety risks. According to AP, the new framework would still leave the majority of products, considered low-risk, on the market. Currently, the FDA does not review safety or effectiveness of homeopathic products and some have recently been the source of major safety problems, such as teething tablets that were tied to seizures and deaths in infants and children. The agency is taking comments for 90 days before it finalizes its plan.
A bipartisan measure that would stabilize Affordable Care Act (ACA) insurer markets is expected to be included in the government funding bill. The bill has to pass by Friday, December 22, to avert a government shutdown, but the inclusion of the ACA fix may set up a showdown with conservatives, reported The Hill. Senate Majority Leader Mitch McConnell, R-Kentucky, pledged to Senator Susan Collins, R-Maine, that he would support passage of the ACA fix in exchange for her vote on the GOP tax bill, and McConnell also told Senator Lamar Alexander, R-Tennessee, that there would be action on the bipartisan measure before the end of the year.
With no new funding for the Children’s Health Insurance Program (CHIP), Alabama has become the first state to announce it is cutting coverage. Kaiser Health News reported Alabama will drop coverage for 7000 kids on January 1, 2018, and will freeze enrollment. If Congress doesn’t act, then the state will close CHIP entirely on February 1, 2018. Other states, including Colorado and Virginia, have begun informing parents that their CHIP programs may also be cut. The director of Alabama’s CHIP program estimates that fewer than 10% of CHIP enrollees will be able to qualify for Medicaid.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More